Yunzhong Pharmaceutical Co., Ltd. announce that it will receive CNY 20 million in round of funding on February 22, 2024. The transaction include the participation from returning investors Yixintang Pharmaceutical Group Co., Ltd., hold 94.29% and individual investor Zhu Lifang, hold 5.71% stake in the company. The company's registered capital is increase from CNY 50 million to CNY 70 million.

The transaction has been approved by sixth meeting of the sixth board of directors and Sixth Meeting of the Sixth Supervisory Board of the investor.